SCHEMBL7078282

SCHEMBL7078282

CC(=O)c1cc(Cc2ccccn2)cc(CN2CCCS2(=O)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYP11B2 P19099 2/20 0.38
TSHR P16473 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SYK P43405 2/20 0.36
AURKB Q96GD4 1/20 0.36
INCENP Q9NQS7 1/20 0.36
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
IDH1 O75874 1/20 0.35
GCK P35557 1/20 0.35
GRM2 Q14416 1/20 0.35
CNR2 P34972 1/20 0.35
GRIA2 P42262 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082794 0.82 KMT2A (0.35) KMT2ACYP1A2CYP2C19KDM4EALDH1A1
SCHEMBL7082837 0.82 LMNA (0.43) KMT2ACYP11B2ALDH1A1GRM2MEN1
SCHEMBL7082096 0.82 SMO (0.36) KMT2ACYP1A2CYP2C19IDH1GRM2
SCHEMBL7079761 0.81 SMN1; SMN2 (0.49) CYP1A2CYP2C19TSHRNPC1RAB9A
SCHEMBL6490222 0.79 FEN1 (0.43) KMT2ACYP1A2CYP2C19CYP11B2IDH1
SCHEMBL6482287 0.76 SYK (0.47) CYP1A2CYP2C19TSHRNPC1RAB9A
SCHEMBL7078271 0.74 LMNA (0.44) KMT2AALDH1A1L3MBTL1NPSR1MEN1
SCHEMBL7077505 0.72 ACKR3 (0.36) GRM2GRIA2
SCHEMBL7082835 0.71 LMNA (0.43) KMT2AALDH1A1L3MBTL1MEN1MAPT
SCHEMBL6480278 0.70 FEN1 (0.46) KMT2ACYP11B2SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 KMT2A 3589/4885CYP1A2 178/4885CYP2C19 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.